MedPath

Evaluation of TDCS for augmentation treatment of major depressive disorder with poor treatment response

Not Applicable
Conditions
Major depressive disorder.
Mild depressive episode
Registration Number
IRCT2016012526189N1
Lead Sponsor
dr. Masud yunesian.manager of research affairs of Tehran University of Medical Sciencses
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

patient with MDD diagnosis due to DSM4 criteria; 20-60 years old; minimum education: 5 class; 8 week treatment by efficient dose of SSRIs and inappropriate response that reffer for TDCs by their psychiatrist plus drug treatment concurrently; probablity of bipolarity and medical problem such as hypothyroidism and acute social problem cause treatment resistance must be evaluate by psychiatrist befor study.
Exclusin criteria: suicidal thought, psychosis, other psychiatric comorbidity except anxiety disorders; personality disorders, substance and alcohol abuse and dependency norologic disease( seizure, stroke, history of traumatic brain injury, life threatening problem in axis 3; metal things in brain or heart; pregnancy; lactation; disagreement to continue the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
?Depression rate. Timepoint: Before, immediately after and 3 months after treatment. Method of measurement: Hamilton depression rating scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath